Wire report
Immunotherapy could be used to treat depression, early trial suggests
UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial. Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression. Continue reading...
coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial. Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression. Continue reading...
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to The Guardian’s linked item, Immunotherapy could be used to treat depression, early trial suggests, UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial. Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression. Continue reading…
Context
The development sits in VINI’s Science coverage for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The linked item is dated 2026-05-20T15:00:47+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Immunotherapy could be used to treat depression, early trial suggests via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- Immunotherapy could be used to treat depression, early trial suggestsThe Guardian - 2026-05-20T15:00:47+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.